DK0791577T3 - Ortho-substituerede benzolguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnosti - Google Patents

Ortho-substituerede benzolguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnosti

Info

Publication number
DK0791577T3
DK0791577T3 DK97100777T DK97100777T DK0791577T3 DK 0791577 T3 DK0791577 T3 DK 0791577T3 DK 97100777 T DK97100777 T DK 97100777T DK 97100777 T DK97100777 T DK 97100777T DK 0791577 T3 DK0791577 T3 DK 0791577T3
Authority
DK
Denmark
Prior art keywords
benzolguanidines
diagnostics
ortho
drug
substituted
Prior art date
Application number
DK97100777T
Other languages
Danish (da)
English (en)
Inventor
Udo Dr Albus
Joachim Dr Brendel
Heinz-Werner Dr Kleemann
Hans Jochen Dr Lang
Wolfgang Dr Scholz
Jan-Robert Dr Schwark
Andreas Dr Weichert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0791577T3 publication Critical patent/DK0791577T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK97100777T 1996-02-22 1997-01-20 Ortho-substituerede benzolguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnosti DK0791577T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19606509A DE19606509A1 (de) 1996-02-22 1996-02-22 Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
DK0791577T3 true DK0791577T3 (da) 2000-04-25

Family

ID=7786043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97100777T DK0791577T3 (da) 1996-02-22 1997-01-20 Ortho-substituerede benzolguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnosti

Country Status (30)

Country Link
US (1) US5856574A (cs)
EP (1) EP0791577B1 (cs)
JP (1) JP3974677B2 (cs)
KR (1) KR100476796B1 (cs)
CN (1) CN1060764C (cs)
AR (1) AR005933A1 (cs)
AT (1) ATE186296T1 (cs)
AU (1) AU723096B2 (cs)
BR (1) BR9701046A (cs)
CA (1) CA2198176A1 (cs)
CZ (1) CZ287843B6 (cs)
DE (2) DE19606509A1 (cs)
DK (1) DK0791577T3 (cs)
ES (1) ES2140922T3 (cs)
GR (1) GR3032293T3 (cs)
HR (1) HRP970101B1 (cs)
HU (1) HUP9700502A3 (cs)
ID (1) ID16042A (cs)
IL (1) IL120259A (cs)
MX (1) MX9701323A (cs)
MY (1) MY117642A (cs)
NO (1) NO307046B1 (cs)
NZ (1) NZ314268A (cs)
PL (1) PL185752B1 (cs)
RU (1) RU2218329C2 (cs)
SI (1) SI0791577T1 (cs)
SK (1) SK281753B6 (cs)
TR (1) TR199700144A2 (cs)
TW (1) TW404937B (cs)
ZA (1) ZA971514B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19713427A1 (de) * 1997-04-01 1998-10-08 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CN111099959B (zh) * 2019-12-30 2022-09-02 西安瑞联新材料股份有限公司 一种1,4-二溴-2,5-二碘苯的工业化生产方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE157351T1 (de) * 1993-02-20 1997-09-15 Hoechst Ag Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament, als inhibitoren des zellulären na+/h+-austauschs oder als diagnostikum sowie sie enthaltendes medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19517848A1 (de) * 1995-05-16 1996-11-21 Merck Patent Gmbh Fluorhaltige Benzoylguanidine
US5596407A (en) * 1995-06-07 1997-01-21 Varian Associates, Inc Optical detector for echelle spectrometer

Also Published As

Publication number Publication date
DE19606509A1 (de) 1997-08-28
IL120259A0 (en) 1997-06-10
EP0791577A1 (de) 1997-08-27
CA2198176A1 (en) 1997-08-22
NO970798L (no) 1997-08-25
DE59700640D1 (de) 1999-12-09
AU1477397A (en) 1997-08-28
HRP970101B1 (en) 2001-02-28
NZ314268A (en) 1997-11-24
HUP9700502A2 (en) 1997-12-29
IL120259A (en) 2001-05-20
PL318417A1 (en) 1997-09-01
KR100476796B1 (ko) 2005-07-21
HRP970101A2 (en) 1998-04-30
BR9701046A (pt) 1998-12-15
ES2140922T3 (es) 2000-03-01
CZ287843B6 (en) 2001-02-14
HU9700502D0 (en) 1997-04-28
NO970798D0 (no) 1997-02-21
TR199700144A2 (tr) 1997-09-21
JPH09227496A (ja) 1997-09-02
RU2218329C2 (ru) 2003-12-10
MY117642A (en) 2004-07-31
CN1161960A (zh) 1997-10-15
AU723096B2 (en) 2000-08-17
MX9701323A (es) 1997-08-30
CZ52897A3 (cs) 1998-06-17
TW404937B (en) 2000-09-11
SI0791577T1 (en) 2000-02-29
SK23797A3 (en) 1997-11-05
AR005933A1 (es) 1999-07-21
ZA971514B (en) 1997-08-22
GR3032293T3 (en) 2000-04-27
ATE186296T1 (de) 1999-11-15
PL185752B1 (pl) 2003-07-31
US5856574A (en) 1999-01-05
ID16042A (id) 1997-08-28
SK281753B6 (sk) 2001-07-10
CN1060764C (zh) 2001-01-17
JP3974677B2 (ja) 2007-09-12
EP0791577B1 (de) 1999-11-03
HUP9700502A3 (en) 1998-01-28
NO307046B1 (no) 2000-01-31
KR970061861A (ko) 1997-09-12

Similar Documents

Publication Publication Date Title
NO993003L (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
DK0771788T3 (da) Substituerede sulfonimidamider, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnostikum og
NO881164D0 (no) Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter.
NO973850L (no) Fenylsubstituerte alkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostika såvel som medikamenter inneholdende dem
FI893557A (fi) Polyestrar, som innehaoller en eterbrygga.
DK373787D0 (da) Substituerede hydrazoner, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel
FI860983A0 (fi) Broms som maetar moment, saerskilt foer hissar.
DK0810206T3 (da) Substituerede 2-naphthoylguanidiner, fremgangsmåder til deres fremstilling, deres avendelse som medikament eller diagnostik
DK0723956T3 (da) Basisk substituerede benzoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnos
NO962006L (no) Substituerte benzyloksykarbonylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som legemiddel inneholdende dem
FI901386A0 (fi) Fasseparationsbehaollare med fasta medel som foerhindrar onblandning.
NO20010219L (no) Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel
NO952596D0 (no) Orto-aminosubstituerte benzoylguandiner, fremgangsmåter for deres fremstilling, deres anvendelse som legemiddel eller diagnostikum såvel som medikamenter som inneholder dem
NO964053D0 (no) Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO972527D0 (no) Orto-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende benzoylguanidinene
NO882112L (no) Substituerte vinylcefalosporiner, fremgangsmaate til deresfremstilling og deres anvendelse som legemiddel.
DK0791577T3 (da) Ortho-substituerede benzolguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnosti
DK1097140T3 (da) Imidazolderivater med biphenylsubstitution, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum og lægemiddel som indeholder dem
NO962999D0 (no) Fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum, såvel som medikament inneholdende dem
NO890096L (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
ITTO950478A0 (it) Rotore per elicotteri.
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
DK231089A (da) Substituerede azolthioethere, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempelsesmiddel
NO972793D0 (no) Orto-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO970697D0 (no) Substituerte tiofenalkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsene